Home | Sitemap | Contact Us | FAQs | Links | Publications | Press | Speeches |

• About Us
  • Introduction
  • Contact us
  • Customer Service
  • DCYA Strategy
  • Designated Public Officials
  • Framework of Assignments
  • Organisation Structure
  • State Boards
• Minister for Children and Youth Affairs
• Childcare
  • What we do
  • Affordable Childcare Scheme
  • Free Pre-School year in Early Childhood Care and Education (ECCE) Programme
  • Community Childcare Subvention (CCS) Programme
  • Training and Employment Childcare (TEC) Programmes
  • City/County Childcare Committees (CCCs)
  • Childcare Regulations
  • Pre-School Inspections
  • Childminders
  • Early Years Education-Focused Inspections
  • Information for Parents
  • Qualifications
  • Childcare Initiatives
• Tusla
  • Overview
  • Contact Tusla
  • Board and CEO
  • Governance and Performance
• Children In Care
  • Introduction
  • Coming Into Care
  • Pathway Into Care
  • What Can you Expect When in Care?
  • Role of Social Workers and Gardaí
  • Aftercare
  • Legislation, Regulations and Standards
  • Reports, Data and Fact Sheets
• Participation
  • What we do
  • Comhairle na nÓg
  • Dáil na nÓg
  • Consultations
  • National Strategy on Participation of Children in Decision Making
  • Children and Young People's Participation Support Team
  • Participation Hub
• Play, Recreation & Culture
  • Play & Recreation
  • Culture
• Children and Young People's Participation Hub
  • Children's Participation Hub Database
  • Developing the Hub
• Child Welfare and Protection
  • What We Do
  • North South Ministerial Council
  • FAQ
• Children First
  • Overview & FAQs
  • Children First Legislation
  • Children First Guidance
  • Children First Implementation
  • DCYA Child Protection Policy
• Adoption
• Irish Youth Justice Service
• Youth Affairs
  • What We Do
  • Funding
  • Programmes
  • Policies & Initiatives
  • Young Voices!!
  • Further Information
• Area Based Childhood (ABC) Programme
  • Overview
• Mother and Baby Homes Investigation
• Children and Young People's Services Committees (CYPSC)
  • CYPSC
• Reform of Guardian ad litem Arrangements
• Quality and Capacity Building Initiative
  • QCBI
• Better Outcomes, Brighter Futures
  • Better Outcomes, Brighter Futures
  • Advisory Council
  • Publications
  • Survey
• Legislation
• International Framework
  • UNCRC
  • EU and Council of Europe
• Research
  • What we do
  • Children's Funded Research Programme
  • National Set of Child Well Being Indicators
  • Measuring Child Well Being
  • State of the Nation's Children Report
  • Research Placement Programme
  • Research Scholarship Programme
  • Research Briefing Notes
  • FAQ
• Growing Up in Ireland
  • DCYA/IRC Scholarship
  • Growing Up in Ireland Phase 1
  • Growing Up In Ireland Publications
• National Research and Data Strategy
  • Background to the Strategy
  • Action Plan Updates
  • Inventory of Data Sources
  • Research Development Initiative Briefing Notes
• Children's Database
• Financial Information
  • Prompt Payments
  • Purchase Orders for €20,000 or above
  • Purchasing & Procurement Information
• Freedom of Information

Irish Child Health Database - Peer Reviewed Papers

Database Search

• Postnatal steroids and chronic lung disease in the newborn

  Published in:

  Paediatr Respir Rev, Vol: 5 Suppl A, Page: S245-8

  Publication Date:

  2004

  Aims & Objectives:

  This article discusse systematic reviews of randomised controlled trials of postnatal steroids (either systemic or inhaled) for CLD in the Cochrane Library were evaluated as a guide to clinical practice

  Abstract:

  INTRODUCTION: Chronic lung disease (CLD) represents a condition of persistent inflammation within the airways which may have its origin either in utero or after birth. Corticosteroids, because of their anti- inflammatory actions, have been used to modify the course of CLD. There have been almost 40 randomised controlled trials of postnatal dexamethasone and 12 of inhaled steroids. METHODS: Systematic reviews of randomised controlled trials of postnatal steroids (either systemic or inhaled) for CLD in the Cochrane Library were evaluated as a guide to clinical practice. Results are presented as relative risks (RR), numbers needed to treat (NNT) or harm (NNH) each with 95% confidence intervals (CI). RESULTS: Postnatal dexamethasone reduces the incidence of CLD and facilitates earlier extubation but with early treatment there are serious long-term neurological adverse effects. Inhaled steroids used early (<2 wk) reduce the need for later dexamethasone (RR 0.78; 0.62-0.99 and NNT 11; 6-125). Inhaled steroids used late (>2 wk) increase the chances of extubation (RR 0.38; 0.20-0.72 and NNT 3; 2-6) and improve ventilator settings and lung mechanics. There appear to be no serious adverse effects of inhaled steroids but comparative studies suggest that dexamethasone acts more rapidly. CONCLUSIONS: Postnatal dexamethasone at currently recommended doses should be avoided. Lower dose dexamethasone or inhaled steroids might be indicated for ill, ventilator-dependent infants with CLD after the age of 2 weeks. More trials of inhaled steroids should be undertaken and these should include long-term follow-up.

  Authors:

  H. L. Halliday

  Study Type:

  Non Study Papers » Discussion paper, review, commentary, letter »

  Keywords:

  • Chronic Disease
  • Dexamethasone/ therapeutic use
  • Glucocorticoids/ therapeutic use
  • Humans
  • Infant, Newborn
  • Lung Diseases/ drug therapy

  
  

  Geography:

  Northern Ireland (Northern Ireland)